114 related articles for article (PubMed ID: 11569941)
1. CLX-0901 (Calyx Therapeutics).
Barlocco D
Curr Opin Investig Drugs; 2001 May; 2(5):650-3. PubMed ID: 11569941
[TBL] [Abstract][Full Text] [Related]
2. Insulin detemir. Novo Nordisk.
Barlocco D
Curr Opin Investig Drugs; 2003 Apr; 4(4):449-54. PubMed ID: 12808886
[TBL] [Abstract][Full Text] [Related]
3. Exenatide. Amylin/Eli Lilly.
Giannoukakis N
Curr Opin Investig Drugs; 2003 Apr; 4(4):459-65. PubMed ID: 12808888
[TBL] [Abstract][Full Text] [Related]
4. Insulin glulisine. Aventis Pharma.
Barlocco D
Curr Opin Investig Drugs; 2003 Oct; 4(10):1240-4. PubMed ID: 14649217
[TBL] [Abstract][Full Text] [Related]
5. E1-INT (Transition Therapeutics/Novo Nordisk).
von Herrath M
Curr Opin Investig Drugs; 2005 Oct; 6(10):1037-42. PubMed ID: 16259225
[TBL] [Abstract][Full Text] [Related]
6. MK-767. Kyorin/Banyu/Merck.
Calkin AC; Thomas MC; Cooper ME
Curr Opin Investig Drugs; 2003 Apr; 4(4):444-8. PubMed ID: 12808885
[TBL] [Abstract][Full Text] [Related]
7. [Against insulin resistance. Insulin sensitizers].
Verspohl EJ; Weiland F
Pharm Unserer Zeit; 2002; 31(3):280-92. PubMed ID: 12071125
[No Abstract] [Full Text] [Related]
8. Managlinat dialanetil, a fructose-1,6-bisphosphatase inhibitor for the treatment of type 2 diabetes.
Wang Y; Tomlinson B
Curr Opin Investig Drugs; 2007 Oct; 8(10):849-58. PubMed ID: 17907062
[TBL] [Abstract][Full Text] [Related]
9. Eligen insulin--a system for the oral delivery of insulin for diabetes.
Hoffman A; Qadri B
IDrugs; 2008 Jun; 11(6):433-41. PubMed ID: 18509785
[TBL] [Abstract][Full Text] [Related]
10. SomatoKine. Insmed.
Norman P
Curr Opin Investig Drugs; 2003 Apr; 4(4):466-71. PubMed ID: 12808889
[TBL] [Abstract][Full Text] [Related]
11. Saxagliptin, a dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes.
Gallwitz B
IDrugs; 2008 Dec; 11(12):906-17. PubMed ID: 19051153
[TBL] [Abstract][Full Text] [Related]
12. Insulin detemir (levemir), a new long-acting insulin.
Med Lett Drugs Ther; 2006 Jul; 48(1238):54-5. PubMed ID: 16841022
[TBL] [Abstract][Full Text] [Related]
13. Dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes: focus on sitagliptin.
Herman GA; Stein PP; Thornberry NA; Wagner JA
Clin Pharmacol Ther; 2007 May; 81(5):761-7. PubMed ID: 17392725
[TBL] [Abstract][Full Text] [Related]
14. Metformin: diamonds are forever.
Papanas N; Maltezos E; Mikhailidis DP
Expert Opin Pharmacother; 2009 Oct; 10(15):2395-7. PubMed ID: 19678795
[TBL] [Abstract][Full Text] [Related]
15. INT-131, a PPARgamma agonist for the treatment of type 2 diabetes.
Kintscher U; Goebel M
Curr Opin Investig Drugs; 2009 Apr; 10(4):381-7. PubMed ID: 19337960
[TBL] [Abstract][Full Text] [Related]
16. Mitiglinide: a novel agent for the treatment of type 2 diabetes mellitus.
Phillippe HM; Wargo KA
Ann Pharmacother; 2010 Oct; 44(10):1615-23. PubMed ID: 20841518
[TBL] [Abstract][Full Text] [Related]
17. Insuline glusine (Apidra): a new rapid-acting insulin.
Med Lett Drugs Ther; 2006 Apr; 48(1233):33-4. PubMed ID: 16625142
[TBL] [Abstract][Full Text] [Related]
18. Insulin aspart: a review.
Owens D; Vora J
Expert Opin Drug Metab Toxicol; 2006 Oct; 2(5):793-804. PubMed ID: 17014395
[TBL] [Abstract][Full Text] [Related]
19. Drug evaluation: rivoglitazone, a new oral therapy for the treatment of type 2 diabetes.
Schimke K; Davis TM
Curr Opin Investig Drugs; 2007 Apr; 8(4):338-44. PubMed ID: 17458185
[TBL] [Abstract][Full Text] [Related]
20. Drug evaluation: tagatose in the treatment of type 2 diabetes and obesity.
Moore MC
Curr Opin Investig Drugs; 2006 Oct; 7(10):924-35. PubMed ID: 17086938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
